Media Mosiac Gov Solutions Book a Strategy Call
Gov.MediaMosiac β€Ί GovCon News
πŸ› GovCon Intel Opportunities Presolicitations Contract Awards Award Notices Grants Events Regulatory Search πŸ“ Insights
← Back to Regulatory Updates

Prospective Grant of an Exclusive Patent License: RXFP1 AGONISTS

Notice πŸ’¬ Comment by Aug 24 (25d left)
Health and Human Services Department, National Institutes of Health
Notice
July 23, 2026
2026-14848
August 24, 2026 (25 days left)

πŸ“„ Summary

The National Center for Advancing Translational Sciences, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this Notice to Modala Bio, Inc. (Modala), headquartered in Delaware.
🎯 Get GovCon Intel Free β†’